Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-24 @ 8:03 PM
NCT ID:
NCT01805804
Eligibility Criteria:
Inclusion Criteria:
* informed written consent
* age ≥ 18 years
* first time pacemaker implantation for trifascicular block, atrioventricular second or third degree block
* left ventricle ejection fraction ≥ 40%
Exclusion Criteria:
* significant valvular heart disease
* ischaemic heart disease requiring further revascularization
* symptomatic hypotension
* orthostatic disorders
* pregnancy, breast feeding, child bearing potential
* previous use of angiotensin receptor blocking agents
* known hypersensitivity to valsartan
* significant liver disorders
* significant renal disorders, including renal artery stenosis
* hyperaldosteronism
* chronic use of nonsteroid antiinflammatory drugs
* chronic use of lithium salts
* Patient's reluctance or disability to obey protocol and/or follow the scheduled visits
* any significant disease to reduce the expected life duration \< 12 months
* participation in any other trial within the last 30 days before randomization
* any situation that would put more risk on patient
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01805804
Study Brief:
Protocol Section:
NCT01805804